The pH/GSH responsiveness of the nanosystem promoted intracellular release of dBET6, leading to BRD4 degradation, lung cancer cells and TAMs apoptosis, TME modulation, and subcutaneous and orthotopic lung tumor growth inhibition. Here, BRD4 is linked to lung cancer.